jessevivian's pharmacy blog
On the afternoon of Nov. 27, President Barack Obama signed into law the Drug Quality and Security Act (H.R. 3204). The bill distinguishes compounders engaged in traditional pharmacy practice from those making large volumes of compounded drugs without individual prescriptions as well as defines the Food and Drug Administration’s role in oversight of outsourcing facilities.More »
There have been many reports in both the lay and professional media concerning the Drug Enforcement Administration (DEA) scheduling status of hydrocodone products. This may cause some confusion among pharmacists. Hydrocodone and products containing hydrocodone are Schedule III drugs and will remain so in the near future.More »
"Actavis will be able to sell defined quantities of a generic version or an authorized generic version of reformulated OxyContin as early as next year, according to Purdue Pharma L.P., the manufacturer of the opioid analgesic.More »
UPS settles with feds over its role in shipping drugs from online pharmacies; FedEx still under investigation
According to the American Association for Pharmacy Law (ASPL) Newsletter:(source)
"The Associated Press reported on March 29 that UPS has agreed to pay $40 million in settlement to end a federal probe into its deliveries of drugs shipped by illicit online pharmacies.More »
Update on generic Oxycontin, from the WALL STREET JOURNAL:
There's lots of confusion over the availability of generic OxyContin (oxycodone)now that the patent for the original form of the drug expired on April 16, 2013. It does not appear that generic versions will be available soon however. Beware of online "pharmacies" advertising generic oxycodone availability. They are usually fakes or substandard versions.More »
Questions about the role of people who help navigate insurance benefits under the new ACA provisions.
"House Republicans want more information about the Obama administration's $54 million grants to help people navigate the new insurance marketplaces created by the Affordable Care Act.More »
Tags: health care navigators
"According to CNN Money: The FDA’s definition of bioequivalence is surprisingly broad: A generic’s maximum concentration of active ingredient in the blood must not fall more than 20% below or 25% above that of the brand name. This means a potential range of 45%, by that measure, among generics labeled as being the same.More »
Federal regulators will let a Pennsylvania university continue to dispense Plan B — also known as the morning-after pill — through a vending machine.
The Food and Drug Administration decided not to intervene following a "politically motivated uproar" over the vending machine Shippensburg University installed in its nurses' office.More »
The FDA and DEA are considering whether to change products like Vicodin containing hydrocodone from Schedule III to Schedule II as a means of deterring diversion and drug abuse.More »